Morgan Stanley initiated coverage on shares of Axon Enterprise (NASDAQ:AXON – Free Report) in a report published on Tuesday, Marketbeat.com reports. The firm issued an equal weight rating and a $230.00 price target on the biotechnology company’s stock. A number of other research firms also recently commented on AXON. JPMorgan Chase & Co. raised Axon […]